Acute hepatitis type C co-infected with GBV-C treated with interferon
Suzuki, H.; Sata, M.; Noguchi, S.; Uchimura, Y.; Tanikawa, K.
American Journal of Gastroenterology 91(12): 2651-2652
1996
ISSN/ISBN: 0002-9270 PMID: 8947017 Document Number: 468987
Document emailed within 1 workday
Related Documents
Desai, H.G.; Gupte, P.A. 2005: Should acute viral C hepatitis be treated with interferon? Indian Journal of Gastroenterology: Official Journal of the Indian Society of Gastroenterology 24(2): 66-67Vogel, M.; Nattermann, J.; Baumgarten, A.; Klausen, G.; Bieniek, B.; Schewe, K.; Jessen, H.; Boesecke, C.; Rausch, M.; Lutz, T.; Fenske, S.; Schranzo, D.; Kümmerle, T.; Schuler, C.; Theisen, A.; Mayr, C.; Seidel, T.; Rockstroh, J.ür.K. 2006: Pegylated interferon-alpha for the treatment of sexually transmitted acute hepatitis C in HIV-infected individuals Antiviral Therapy 11(8): 1097-1101
Łapiński, T.W. 2001: Activation of acute phase proteins in patients with chronic hepatitis C treated with interferon-alpha 2a Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 10(57): 138-142
Calleri, G.; Colombatto, P.; Gozzelino, M.; Chieppa, F.; Romano, P.; Delmastro, B.; Macor, A.; Cariti, G.; Brunetto, M.R.; Grillone, W.; Bonino, F. 1998: Natural beta interferon in acute type-C hepatitis patients: a randomized controlled trial Italian Journal of Gastroenterology and Hepatology 30(2): 181-184
Danilova, L.V.; Popova, E.V.; Kulakova, O.G.; Tsareva, E.I.; Favorov, A.V.; Favorova, O.O.; Boĭko, A.N. 2014: The activation of the type i interferon signaling pathway in multiple sclerosis patients treated with russian analogue of Β-interferon-1b: transcriptome profiling data Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 114(2 Part 2): 72-77
Juszczyk, J. 2003: Place of consensus type interferon alpha in the management of chronic type C hepatitis Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 14(82): 275-278
Stancek, D.; Fuchsberger, N.; Oltman, M.; Schmeisser, H.; Kontsek, P.; Jahnová, E.; Hajnická, V. 2001: Significance of anti-interferon-alpha2 and sICAM-1 activities in the sera of viral hepatitis B and C patients treated with human recombinant interferon-alpha2 Acta Virologica 45(5-6): 287-292
Pivert, A.; Payan, C.; Lunel, F.; C, E.R.T. A. 2004: Comparaison des cinétiques de l'ARN et de l'antigène de capside du virus de l'hépatite C dans le suivi thérapeutique des patients co-infectés par le virus de l'hépatite C et le virus de l'immunodéficience humaine, traités par bithérapie interféron-ribavirine, dans le cadre du protocole RIBAVIC - Comparison of hepatitis C viral RNA and core antigen kinetics in the therapeutic follow up of hepatitis C virus and human immunodeficiency virus co-infected patients, treated by bitherapy interferon-ribavirin, within the framework of RIBAVIC protocol Pathologie et Biologie 52(9): 522-528
Bjøro, K.; Schrumpf, E.; Elgjo, K.; Nordgård, K. 1990: Chronic non-A non-B hepatitis treated with interferon Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 110(11): 1346-1348
Soriano, V.; García-Samaniego, J. 1994: Therapy with interferon in HIV-infected patients with chronic viral hepatitis Revista Clinica Espanola 194(10): 887-889
Ohnishi, K.; Nomura, F.; Nakano, M. 1991: Interferon therapy for acute posttransfusion non-A, non-B hepatitis: response with respect to anti-hepatitis C virus antibody status American Journal of Gastroenterology 86(8): 1041-1049
Kakumu, S.; Ishikawa, T.; Wakita, T.; Yoshioka, K.; Takayanagi, M.; Tahara, H.; Kusakabe, A. 1994: Interferon-gamma production specific for hepatitis B virus antigen by intrahepatic T lymphocytes in patients with acute and chronic hepatitis B American Journal of Gastroenterology 89(1): 92-96
Mrugacz, M.łg.; Lebensztejn, D. 2010: Ocular findings in hepatitis C patients treated with interferon Klinika Oczna 112(7-9): 253-256
Hrycewycz, N.; Sandres, K.; Barange, K.; Pascal, J.P.; Izopet, J.; Payen, J.L. 2001: Eradication of hepatitis C virus after 3 months of interferon and ribavirin treatment in an a interferon non-responder patient with chronic hepatitis C Gastroenterologie Clinique et Biologique 25(11): 1041-1042
Heldenberg, D.; Weizer, S. 1989: Acute type A hepatitis and acute glomerulonephritis in a carrier of hepatitis B antigen Harefuah 116(12): 637-638
Almasio, P.; Mirto, S.; Malleo, C.; Di Marco, V.; Caronia, F.; Craxi, A. 1991: Recombinant interferon alpha-2B for acute post-transfusion hepatitis in acute myeloid leukemia Haematologica 76(5): 429-430
Abutidze, A.; Bolokadze, N.; Chkhartishvili, N.; Sharvadze, L.; Tsertsvadze, T. 2016: Incidence of Tuberculosis among Hiv/Hcv Co-Infected Patients Receiving Hepatitis C Treatment with Pegylated Interferon and Ribavirin in Georgia Georgian Medical News 252: 10-15
Nakamura, H.; Ogawa, H.; Kuroda, T.; Yamamoto, M.; Enomoto, H.; Kishima, Y.; Yoshida, K.; Ito, H.; Matsuda, M.; Noguchi, S. 2002: Interferon treatment for patients with chronic hepatitis C infected with high viral load of genotype 2 virus Hepato-Gastroenterology 49(47): 1373-1376
Karim, A.; Ahmed, S.; Khan, A.; Steinberg, H.; Mattana, J. 2001: Interstitial pneumonitis in a patient treated with alpha-interferon and ribavirin for hepatitis C infection American Journal of the Medical Sciences 322(4): 233-235
Okano, J.; Horie, Y.; Kawasaki, H.; Kondo, M. 1997: Interferon treatment of porphyria cutanea tarda associated with chronic hepatitis type C Hepato-Gastroenterology 44(14): 525-528